Genetic manipulation of adhesion GPCR CD97/ADGRE5 modulates invasion in patient-derived glioma stem cells

D. G. Eichberg,T. I. Slepak,A. L. Pascoini,R. J. Komotar,M. E. Ivan
DOI: https://doi.org/10.1007/s11060-021-03778-8
2021-05-24
Abstract:Effective glioblastoma (GBM) treatment is limited by high invasiveness and heterogeneity. Current therapies target proliferating Glioma Stem Cell (GSC) subpopulations while sparing invading GSCs, which eventually engender tumor recurrence after treatment. Surface receptor CD97/ADRGE5 is associated with invasion and metastasis regulation in non-CNS cancers. Although CD97 expression level positively correlates with poor GBM patient prognosis, its role in this tumor is unclear.
oncology,clinical neurology
What problem does this paper attempt to address?